Q&A HIPEC A
Furthering Survivorship for GYN Cancer Patients
Robert DeBernardo, MD, is a gynecologic oncologist who is leading a team at UH Seidman Cancer Center where one of the first dedicated HIPEC gynecologic programs in the nation is being launched.
TEAM OF CANCER specialists at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center is among the first in the nation to
launch a dedicated gynecologic program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other malignancies. The team, which includes medical and surgical oncologists, intensivists, perfusionists and chemotherapy nurses, is led by Robert DeBernardo, MD, a gynecologic oncologist and assistant professor at Case Western Reserve University School of Medicine. MD News recently asked Dr. DeBernardo about HIPEC and its advantages.
22 | Cleveland-Akron-Canton MD NEWS n MDNEWS.COM n MARCH-APRIL 2012
